217 related articles for article (PubMed ID: 27025829)
1. A Randomized Trial of Clindamycin Versus Trimethoprim-sulfamethoxazole for Uncomplicated Wound Infection.
Talan DA; Lovecchio F; Abrahamian FM; Karras DJ; Steele MT; Rothman RE; Krishnadasan A; Mower WR; Hoagland R; Moran GJ
Clin Infect Dis; 2016 Jun; 62(12):1505-1513. PubMed ID: 27025829
[TBL] [Abstract][Full Text] [Related]
2. Effect of Cephalexin Plus Trimethoprim-Sulfamethoxazole vs Cephalexin Alone on Clinical Cure of Uncomplicated Cellulitis: A Randomized Clinical Trial.
Moran GJ; Krishnadasan A; Mower WR; Abrahamian FM; LoVecchio F; Steele MT; Rothman RE; Karras DJ; Hoagland R; Pettibone S; Talan DA
JAMA; 2017 May; 317(20):2088-2096. PubMed ID: 28535235
[TBL] [Abstract][Full Text] [Related]
3. Clindamycin versus trimethoprim-sulfamethoxazole for uncomplicated skin infections.
Miller LG; Daum RS; Creech CB; Young D; Downing MD; Eells SJ; Pettibone S; Hoagland RJ; Chambers HF;
N Engl J Med; 2015 Mar; 372(12):1093-103. PubMed ID: 25785967
[TBL] [Abstract][Full Text] [Related]
4. A Placebo-Controlled Trial of Antibiotics for Smaller Skin Abscesses.
Daum RS; Miller LG; Immergluck L; Fritz S; Creech CB; Young D; Kumar N; Downing M; Pettibone S; Hoagland R; Eells SJ; Boyle MG; Parker TC; Chambers HF;
N Engl J Med; 2017 Jun; 376(26):2545-2555. PubMed ID: 28657870
[TBL] [Abstract][Full Text] [Related]
5. Trimethoprim-Sulfamethoxazole versus Placebo for Uncomplicated Skin Abscess.
Talan DA; Mower WR; Krishnadasan A; Abrahamian FM; Lovecchio F; Karras DJ; Steele MT; Rothman RE; Hoagland R; Moran GJ
N Engl J Med; 2016 Mar; 374(9):823-32. PubMed ID: 26962903
[TBL] [Abstract][Full Text] [Related]
6. Dose of trimethoprim-sulfamethoxazole to treat skin and skin structure infections caused by methicillin-resistant Staphylococcus aureus.
Cadena J; Nair S; Henao-Martinez AF; Jorgensen JH; Patterson JE; Sreeramoju PV
Antimicrob Agents Chemother; 2011 Dec; 55(12):5430-2. PubMed ID: 21930870
[TBL] [Abstract][Full Text] [Related]
7. What Is the Evidence for Co-trimoxazole, Clindamycin, Doxycycline, and Minocycline in the Treatment of Methicillin-Resistant
Hong J; Ensom MHH; Lau TTY
Ann Pharmacother; 2019 Nov; 53(11):1153-1161. PubMed ID: 31177803
[No Abstract] [Full Text] [Related]
8. Trimethoprim-sulfamethoxazole or clindamycin for community-associated MRSA (CA-MRSA) skin infections.
Frei CR; Miller ML; Lewis JS; Lawson KA; Hunter JM; Oramasionwu CU; Talbert RL
J Am Board Fam Med; 2010; 23(6):714-9. PubMed ID: 21057066
[TBL] [Abstract][Full Text] [Related]
9. Clinical outcomes in patients hospitalized with cellulitis treated with oral clindamycin and trimethoprim/sulfamethoxazole: The role of weight-based dosing.
Cox KK; Alexander B; Livorsi DJ; Heintz BH
J Infect; 2017 Dec; 75(6):486-492. PubMed ID: 28919346
[TBL] [Abstract][Full Text] [Related]
10. Treatment of experimental endocarditis due to methicillin-susceptible or methicillin-resistant Staphylococcus aureus with trimethoprim-sulfamethoxazole and antibiotics that inhibit cell wall synthesis.
de Górgolas M; Avilés P; Verdejo C; Fernández Guerrero ML
Antimicrob Agents Chemother; 1995 Apr; 39(4):953-7. PubMed ID: 7786002
[TBL] [Abstract][Full Text] [Related]
11. Increasing clindamycin resistance among methicillin-resistant Staphylococcus aureus in 57 northeast United States military treatment facilities.
Braun L; Craft D; Williams R; Tuamokumo F; Ottolini M
Pediatr Infect Dis J; 2005 Jul; 24(7):622-6. PubMed ID: 15999004
[TBL] [Abstract][Full Text] [Related]
12. Treatment of methicillin-resistant Staphylococcus aureus infections with a minimal inhibitory concentration of 2 μg/mL to vancomycin: old (trimethoprim/sulfamethoxazole) versus new (daptomycin or linezolid) agents.
Campbell ML; Marchaim D; Pogue JM; Sunkara B; Bheemreddy S; Bathina P; Pulluru H; Chugh N; Wilson MN; Moshos J; Ku K; Hayakawa K; Martin ET; Lephart PR; Rybak MJ; Kaye KS
Ann Pharmacother; 2012 Dec; 46(12):1587-97. PubMed ID: 23212935
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial Resistance Patterns of Outpatient Staphylococcus aureus Isolates.
Carrel M; Smith M; Shi Q; Hasegawa S; Clore GS; Perencevich EN; Goto M
JAMA Netw Open; 2024 Jun; 7(6):e2417199. PubMed ID: 38874923
[TBL] [Abstract][Full Text] [Related]
14. In vivo bioluminescence imaging to evaluate systemic and topical antibiotics against community-acquired methicillin-resistant Staphylococcus aureus-infected skin wounds in mice.
Guo Y; Ramos RI; Cho JS; Donegan NP; Cheung AL; Miller LS
Antimicrob Agents Chemother; 2013 Feb; 57(2):855-63. PubMed ID: 23208713
[TBL] [Abstract][Full Text] [Related]
15. Trimethoprim-sulfamethoxazole-induced hepatotoxicity in a pediatric patient.
Bell TL; Foster JN; Townsend ML
Pharmacotherapy; 2010 May; 30(5):539. PubMed ID: 20412003
[TBL] [Abstract][Full Text] [Related]
16. Increasing Clindamycin and Trimethoprim-Sulfamethoxazole Resistance in Pediatric Staphylococcus aureus Infections.
Khamash DF; Voskertchian A; Tamma PD; Akinboyo IC; Carroll KC; Milstone AM
J Pediatric Infect Dis Soc; 2019 Sep; 8(4):351-353. PubMed ID: 30011009
[TBL] [Abstract][Full Text] [Related]
17. A decade of antimicrobial resistance in Staphylococcus aureus: A single center experience.
Vicetti Miguel CP; Mejias A; Leber A; Sanchez PJ
PLoS One; 2019; 14(2):e0212029. PubMed ID: 30753206
[TBL] [Abstract][Full Text] [Related]
18. Prevalence, severity, and treatment of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) skin and soft tissue infections in 10 medical clinics in Texas: a South Texas Ambulatory Research Network (STARNet) study.
Forcade NA; Parchman ML; Jorgensen JH; Du LC; Nyren NR; Treviño LB; Peña J; Mann MW; Muñoz A; Treviño SB; Mortensen EM; Wickes BL; Pollock BH; Frei CR
J Am Board Fam Med; 2011; 24(5):543-50. PubMed ID: 21900437
[TBL] [Abstract][Full Text] [Related]
19. Trimethoprim-Sulfamethoxazole for Pediatric Osteoarticular Infections.
McDaniel LM; Fiawoo S; Tamma PD; Same RG
J Pediatric Infect Dis Soc; 2023 Oct; 12(10):534-539. PubMed ID: 37757866
[TBL] [Abstract][Full Text] [Related]
20. Determination of antimicrobial susceptibility patterns in Staphylococcus aureus strains recovered from patients at two main health facilities in Kabul, Afghanistan.
Naimi HM; Rasekh H; Noori AZ; Bahaduri MA
BMC Infect Dis; 2017 Nov; 17(1):737. PubMed ID: 29187146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
